Science To Valuation
| BEUT Stock | USD 0.0001 0.00 0.00% |
Science To seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Science to Consumers from inspecting the company fundamentals such as Net Income of (58.7 K), shares owned by insiders of 65.78 %, and Return On Asset of -4.4 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Science To's price fluctuation is very steady at this time. Calculation of the real value of Science to Consumers is based on 3 months time horizon. Increasing Science To's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Science To's intrinsic value may or may not be the same as its current market price of 0.0001, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Science To's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Science To's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Science to Consumers helps investors to forecast how Science pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Science To more accurately as focusing exclusively on Science To's fundamentals will not take into account other important factors: Science To Total Value Analysis
Science to Consumers is currently anticipated to have valuation of 1.18 M with market capitalization of 1.13 M, debt of 0, and cash on hands of 1.44 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Science To fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.18 M | 1.13 M | 0 | 1.44 K |
Science To Asset Utilization
One of the ways to look at asset utilization of Science is to check how much profit was generated for every dollar of assets it reports. Science to Consumers has a negative utilization of assets of -4.4 %, losing $0.044 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Science to Consumers shows how discouraging it operates for each dollar spent on its assets.Science To Ownership Allocation
Science to Consumers shows a total of 31.92 Million outstanding shares. Science to Consumers has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.78 % of Science To outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Science To Profitability Analysis
Net Loss for the year was (58.7 K) with profit before overhead, payroll, taxes, and interest of 0.About Science To Valuation
The pink sheet valuation mechanism determines Science To's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Science to Consumers based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Science To. We calculate exposure to Science To's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Science To's related companies.Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name and distributing Argan oil products. Science to Consumers, Inc. was founded in 2013 and is based in Guangzhou, China. Science To is traded on OTC Exchange in the United States.
8 Steps to conduct Science To's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Science To's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Science To's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Science To's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Science To's revenue streams: Identify Science To's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Science To's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Science To's growth potential: Evaluate Science To's management, business model, and growth potential.
- Determine Science To's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Science To's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Science Pink Sheet Analysis
When running Science To's price analysis, check to measure Science To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science To is operating at the current time. Most of Science To's value examination focuses on studying past and present price action to predict the probability of Science To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science To's price. Additionally, you may evaluate how the addition of Science To to your portfolios can decrease your overall portfolio volatility.